10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
13.16
-0.16 (-1.20%)
Nov 21, 2024, 11:04 AM EST - Market open
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $1.59 billion as of November 21, 2024. Its market cap has decreased by -65.46% in one year.
Market Cap
1.59B
Enterprise Value
1.30B
1-Year Change
-65.46%
Ranking
Category
Stock Price
$13.16
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from $4.95B to $1.59B, a decrease of -67.82%. That is a compound annual growth rate of -19.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 1.61B | -75.62% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | 15.24B | 107.79% |
| Dec 31, 2019 | 7.33B | 48.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GoodRx Holdings | 1.64B |
| Xencor | 1.62B |
| Viridian Therapeutics | 1.61B |
| Certara | 1.61B |
| Clover Health Investments | 1.60B |
| Arvinas | 1.59B |
| Neumora Therapeutics | 1.59B |
| Teladoc Health | 1.56B |